본문 바로가기
KERD
논문KCI 등재

내장지방의 임상적 의의

Cinical Significance of Visceral Adipose Tissue

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류가정의학

초록

비만은 심혈관질환과 당뇨병 및 사망률을 증가시키는 건강 위험 요인이다. 최근 연구들에서는 비만인에서 체지방량보다 체지방 분포가 건강 위험과 더 관련 있다고 보고하고 있다. 실제로 내장지방이 과다한 경우 심혈관질환, 대사증후군, 당뇨병, 이상지질혈증 및 사망률과 관련이 있다. 내장지방은 해부학적 위치와 대사적 특징으로 심혈관질환 및 대사장애와 연관이 높다. 한국인은 서양인에 비해 체질량지수가 낮지만 심혈관질환과 대사증후군의 유병률이 높기 때문에 내장지방의 정도를 평가하는 것이 필요하다. 내장지방의 평가는 간단한 허리둘레측정이나 컴퓨터단층촬영 혹은 자기공명영상과 같은 정확한 방법을 이용할 수 있다. 내장지방 감소를 위해서는 적절한 식사요법, 운동요법 그리고 경우에 따라 약물요법을 사용할 수 있디.

참고문헌 (79)

  1. Matsuzawa Y, "White adipose tissue and cardiovascular disease", 19, pp.637~647 (2005)
  2. Desprs JP, "Treatment of obesity: need to focus on high risk abdominally obese patients", 322, pp.716~720 (2001)
  3. Dixon JB, "A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg", m2, 2001, pp.25, 793~797
  4. Ruderman N, "The metabolically obese, normal-weight individual revisited", 47, pp.699~713 (1998)
  5. Despres JP, "Is visceral obesity the cause of the metabolic syndrome?", 38, pp.52~63 (2006)
  6. Carr DB, "Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome", 53, pp.2087~2094 (2004)
  7. 박혜순, "한국인에서의 대사증후군의 역학", 11, pp.203~211 (2002)
  8. Tokunaga K, "Sexual dimorphism of age-related changes in whole-body fat distribution in the obese", pp.207~2
  9. Pascot A, "Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women", 22, pp.1471~1478 (1999)
  10. Ryan AS, "A cross-sectional study on body composition and energy expenditure in women athletes during aging", 271, pp.E916~E921 (1996)
  11. Gastaldelli A, "Visceral fat and beta cell function in non-diabetic humans", 48, pp.2090~2096 (2005)
  12. Gower BA, "Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use", 14, pp.1046~1055 (2006)
  13. Bouchard C, "Major gene for abdominal visceral fat area in the Quebec Family Study", 20, pp.420~427 (1996)
  14. Rosenberg B, "Insulin resistance (metabolic) syndrome in children", 47, pp.229~244 (2005)
  15. Deurenberg P, "Body mass index and percent body fat: a meta analysis among different ethnic groups", 22, pp.1164~1171 (1998)
  16. WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", 363, pp.157~163 (2004)
  17. Hu FB, "Diet, lifestyle, and the risk of type 2 diabetes mellitus in women", 345, pp.790~797 (2001)
  18. Wannamethee SG, "Alcohol, body weight, and weight gain in middle-aged men", 77, pp.1312~1317 (2003)
  19. Komiya H, "Smoking as a risk factor for visceral fat accumulation in Japanese men", 208, pp.123~132 (2006)
  20. Arner P, "Differences in lipolysis between human subcutaneous and omental adipose tissues", 27, pp.435~438 (1995)
  21. Andersson B, "The morphology and metabolism of intraabdominal adipose tissue in men", pp.1242~8
  22. Andersson B, "Metabolism of adipose tissue in intraabdominal depots of nonobese men and women", pp.453~8
  23. Bolinder J, "Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis", pp.117~23
  24. Freedland ES, "Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review", 1, pp.12~ (2004)
  25. Avogaro A, "Insulin resistance: trigger or concomitant factor in the metabolic syndrome", 48, pp.3~12 (2006)
  26. Matsuzawa Y, "The metabolic syndrome and adipocytokines", 580, pp.2917~2921 (2006)
  27. Matsuzawa Y, "Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease", 3, pp.35~42 (2006)
  28. Bjorntorp P, "Metabolic difference between visceral fat and subcutaneous abdominal fat", 26, pp.10~12 (2000)
  29. Lee SY, "Appropriate waist circumference cutoff points for central obesity in Korean adults", 75, pp.72~80 (2007)
  30. Par A, "Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?", 9, pp.526~534 (2001)
  31. Zhu S, "Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors", 81, pp.409~415 (2005)
  32. Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", 15, pp.539~553 (1998)
  33. Azizi F, "Is there an independent association between waist-to-hip ratio and cardiovascular risk factors in overweight and obese women?", 101, pp.39~46 (2005)
  34. Clasey JL, "The use of anthropometric and dual- energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women", 7, pp.256~264 (1999)
  35. Fuller NJ, "Assessment of the composition of major body regions by dual-energy X-ray absorptiometry with special reference to limb muscle mass", pp.253~66
  36. Snijder MB, "The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry", 26, pp.984~993 (2002)
  37. Zamboni M, "Body fat distribution in pre- and post-menopausal women", pp.495~504
  38. "Examination Committee of Criteria for ‘Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease' in Japan", 66, pp.987~992 (2002)
  39. Fujioka S, "Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity", pp.54~9
  40. Rispoli A, "Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study", pp.771~5
  41. Kawamoto R, "Association between abdominal wall fat index on ultrasonography and carotid atherosclerosis in non-obese men", 12, pp.85~91 (2005)
  42. Despres JP, "Health consequences of visceral obesity", 33, pp.534~541 (2001)
  43. Mori Y, "Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation: a study in pre-diabetic Japanese middle-aged men", 29, pp.149~153 (2006)
  44. Matsuzawa Y, "Visceral fat accumulation and cardiovascular disease", 3, pp.645~647 (1995)
  45. Mochida M, "Visceral fat obesity contributes to the tortuosity of the thoracic aorta on chest radiograph in poststroke Japanese patients", 57, pp.85~91 (2006)
  46. Angulo P, "Nonalcoholic fatty liver disease", 346, pp.1221~1231 (2002)
  47. Schffler A, "Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease", 2, pp.273~280 (2005)
  48. Tsai CJ, "Central adiposity, regional fat distribution, and the risk of cholecystectomy in women", 55, pp.708~714 (2006)
  49. Kono S, "Gallstone disease among Japanese men in relation to obesity, glucose intolerance, exercise, alcohol use, and smoking", 30, pp.372~376 (1995)
  50. Busetto L, "Visceral fat and respiratory complications", 7, pp.301~306 (2005)
  51. Calle EE, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults", 348, pp.1625~1638 (2003)
  52. von Hafe P, "Visceral fat accumulation as a risk factor for prostate cancer", 12, pp.1930~1935 (2004)
  53. Hsing AW, "Prostate cancer risk and serum levels of insulin and leptin: a population-based study", 93, pp.783~789 (2001)
  54. Manson JE, "Body weight and mortality among women", 333, pp.677~685 (1995)
  55. Kaaks R, "Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women", 92, pp.1592~1600 (2000)
  56. Schoen RE, "Increased blood glucose and insulin, body size, and incident colorectal cancer", 91, pp.1147~1154 (1999)
  57. Orio F Jr, "The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study", 89, pp.3696~3701 (2004)
  58. Elting MW, "Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population", 16, pp.556~560 (2001)
  59. Takahashi S, "Close correlation between visceral fat accumulation and uric acid metabolism in healthy men", 46, pp.1162~1165 (1997)
  60. van Swieten JC, "and cognitive function in a population- based study", pp.1246~52
  61. Jagust W, "Central obesity and the aging brain", 62, pp.1545~1548 (2005)
  62. Gustafson D, "A 24-year follow-up of body mass index and cerebral atrophy", 63, pp.1876~1881 (2004)
  63. Gustafson D, "An 18-year follow-up of overweight and risk of Alzheimer disease", 163, pp.1524~1528 (2003)
  64. Kalmijn S, "Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study", 20, pp.2255~2260 (2000)
  65. Weber B, "Major depression and impaired glucose tolerance", 108, pp.187~190 (2000)
  66. Brown ES, "Association of depression with medical illness: does cortisol play a role?", 55, pp.1~9 (2004)
  67. Landn M, "Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety", 29, pp.1037~1046 (2004)
  68. "U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary Guidelines for Americans, 2005"
  69. Chan DC, "Dyslipidemia in visceral obesity: mechanisms, implications, and therapy", 4, pp.227~246 (2004)
  70. Abe T, "Relationship between training frequency and subcutaneous and visceral fat in women", 29, pp.1549~1553 (1997)
  71. Mourier A, "Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements", 20, pp.385~391 (1997)
  72. Pate RR, "Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine", 273, pp.402~407 (1995)
  73. O'Leary VB, "Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat", 100, pp.1584~1589 (2006)
  74. Hauptman JB, "Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647", pp.309~13
  75. Shi YF, "Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes", 22, pp.1737~1743 (2005)
  76. Toplak H, "X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance", 7, pp.699~708 (2005)
  77. Mun EC, "Current status of medical and surgical therapy for obesity", 120, pp.669~681 (2001)
  78. Faria AN, "Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients", 7, pp.246~253 (2005)
  79. Arterburn DE, "The efficacy and safety of sibutramine for weight loss: a systematic review", 164, pp.994~1003 (2004)

이 간행물의 다른 논문 (6건)